EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MOLECULAR BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS

Jawad Ali

Journal of Biosciences and Innovations · 31.12.2023 · 2 (02) · 38-56

DOI: 10.64037/jbi.02.27 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biosciences and Innovations, online erschienen am 31.12.2023. Verfasst von Jawad Ali. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic Lupus Erythematosus (SLE) is a persistent multisystem autoimmune disorder characterized by uncontrolled exacerbations and having heterogeneous clinical manifestations, which requires meticulous assessment of the activity. This research study aimed to determine the diagnostic and prognostic effectiveness of a set of molecular biomarkers; cytotokines, complement proteins, autoantibodies, and gene-expression signatures in the differentiation between active and inactive phases of systemic lupus erythematosus (SLE). The findings showed significant changes in IL-6, TNF-a, IFN-g and anti-dsDNA titer during active disease, but complement C3 and C4 were reduced tremendously indicating continued inflammation due to immune-complexes. Transcriptomic profiling revealed an augmented interferon-stimulated gene (ISG) signature, which is largely connected to flare episodes. Autoantibodies, including anti-Sm and anti-RNP, were correlated significantly with systemic and renal involvement as important to the organ-specific classification of risks. All these data points to the fact that the combination of many molecular indicators increases the accuracy of disease surveillance, allows to predict when a disease will enter a flare, and helps the treatment plan. The article highlights the potential of a biomarker-informed evaluation as one of the pillars of precision medicine in SLE treatment.

Zitieren

APA

Ali, J. (2023). MOLECULAR BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS. Journal of Biosciences and Innovations, 2(02), 38-56. https://doi.org/10.64037/jbi.02.27

Vancouver

Ali J. MOLECULAR BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS. Journal of Biosciences and Innovations. 2023;2(02):38-56. doi:10.64037/jbi.02.27

BibTeX
@article{Ali2023,
  author = {Ali, Jawad},
  title = {MOLECULAR BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS},
  journal = {Journal of Biosciences and Innovations},
  year = {2023},
  volume = {2},
  number = {02},
  pages = {38--56},
  doi = {10.64037/jbi.02.27}
}
Kostenlos starten →